4. ordentliche Generalversammlung der innovAARE AG
(This information is only available in German) Der PARK INNOVAARE markiert einen weiteren wichtigen Meilenstein in seiner Entwicklung: Die Finanzierung...
More details More detailsDr. Fabia Gozzo: an exceptional, creative, inventive, and innovative woman and entrepreneur
In a couple of weeks, London will welcome some of the world’s most innovative women from all sectors and backgrounds. The 21st Global Women Inventors,...
More detailsNovel Accelerators for Electron Diffraction workshop at PARK INNOVAARE
Understanding how matter creates life requires observing living cells with atomic detail. There are many ways to do so, but one possibility has been gaining...
More detailsWE ARE HIRING!
PARK INNIVAARE is an innovation park next to the Paul Scherrer Institute PSI. It offers academic spin-offs, innovative start-ups, SMEs and big companies,...
More detailsA platform to discuss high-level topics with the pharmaceutical industry
Novartis (Switzerland) and Alphora (Canada) joined the case study program conducted as part of the Second Annual Spring Pharmaceutical Synchrotron X-Ray...
More detailsBIC of CERN Technologies calls for innovative ideas leveraging accelerator technologies
As of today, start-ups and spin-offs, as well as small high-tech companies, younger than two years, can apply to become the next Business Incubation Centre...
More detailsInterAx partners with Lundbeck to identify better pharmaceutical compounds
InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...
More detailsExcelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction
The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...
More detailsInterAx raises CHF 3 Mio for the commercialization of its systems biology platform
InterAx Biotech AG is a spin off from the ETH Zürich and Paul Scherrer Institute (PSI). The company assists GPCR drug candidate design and selection by...
More detailsTwo well-known techniques + new application field = breakthrough of the year
This fall, Dr. Tim Grüne from the Paul Scherrer Institute (PSI) together with Crystallise! AG published the results of their joint project, presenting...
More detailsMeeting Swiss innovation elite at Swiss Innovation Forum 2018
Swiss Innovation Forum (#SIF18) – Switzerland's biggest innovation fair – was held on Thursday, November 22, 2018, bringing together over a thousand...
More detailsSecuraxis is the first incubatee of BIC of CERN technologies
The Business Incubation Centre (BIC) of CERN Technologies, launched this summer by PARK INNOVAARE, CERN, the Paul Scherrer Institute (PSI), and the University...
More details